Halozyme Therapeutics (HALO) Cash from Operations (2010 - 2026)
Halozyme Therapeutics (HALO) reported Cash from Operations of $240.89 million for Q2 2026, up 141.6% from $99.71 million a year earlier and up 33.8% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Cash from Operations (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' Cash from Operations came in at $818.6 million, up 49.4% year-over-year; for FY2025, it was $651.56 million, up 36.0% from FY2024.
- Cash from Operations has increased for three consecutive years, with a five-year compound annual growth rate of 63.7% (FY2020 to FY2025).
- By year, Cash from Operations came in at $479.06 million in FY2024 (+23.3%), $388.57 million in FY2023 (+61.8%), $240.11 million in FY2022 (-19.8%) and $299.44 million in FY2021 (+440.0%).
- The Q2 2026 figure ranks as the highest quarterly Cash from Operations in data going back to Q3 2010.
- Year over year, Cash from Operations has now increased in each of the last seven quarters, with growth averaging 49.4% over the last eight quarters.
- The high point for year-over-year Cash from Operations in five years was Q2 2026 (growth of 141.6%); the low point was Q3 2022 (a decline of 42.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $180.08 million (Q1 2026), $219.03 million (Q4 2025) and $178.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 240.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240.89 Mn |
| Mar 31, 2026 | 180.08 Mn |
| Dec 31, 2025 | 219.03 Mn |
| Sep 30, 2025 | 178.60 Mn |
| Jun 30, 2025 | 99.71 Mn |
| Mar 31, 2025 | 154.22 Mn |
| Dec 31, 2024 | 178.47 Mn |
| Sep 30, 2024 | 115.38 Mn |
| Jun 30, 2024 | 55.79 Mn |
| Mar 31, 2024 | 129.43 Mn |
| Dec 31, 2023 | 102.35 Mn |
| Sep 30, 2023 | 132.41 Mn |
| Jun 30, 2023 | 66.84 Mn |
| Mar 31, 2023 | 86.96 Mn |
| Dec 31, 2022 | 82.45 Mn |
| Sep 30, 2022 | 69.64 Mn |
| Jun 30, 2022 | 40.23 Mn |
| Mar 31, 2022 | 47.80 Mn |
| Dec 31, 2021 | 82.52 Mn |
| Sep 30, 2021 | 121.74 Mn |
API Access
Halozyme Therapeutics Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();